RuDiOBn

RuDiOBn scanvages DPPH and ABTS free radicals (13.2% and 5.9% clearance at 100 μg/mL), exhibits low antioxidant activity. RuDiOBn inhibits the collagen glycation, reduces the formation of advanced glycation end products (AGEs) with an IC50 of 2.45 μg/mL. RuDiOBn enhances the proliferation and migration of fibroblasts, stimulates the synthesis of collagen, promoting the skin repair and regeneration. RuDiOBn also inhibits collagenase[1].

Product Specifications

CAS Number

[13459-13-7]

UNSPSC

12352005

Target

MMP; Reactive Oxygen Species (ROS)

Related Pathways

Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Field of Research

Others

Smiles

OC1=C(C(C(O)=C(C2=CC=C(OCC3=CC=CC=C3)C(O)=C2)O4)=O)C4=CC(OCC5=CC=CC=C5)=C1

Molecular Formula

C29H22O7

Molecular Weight

482.48

References & Citations

[1]da Silva BJP, et al., Synthesis of a New Benzylated Derivative of Rutin and Study of Its Cosmetic Applications. ACS Omega. 2025 Feb 28;10 (9) :8883-8890.